advisorsecurities master

VALNValneva SE American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key
23216
Ticker
VALN
Type
ADRCAmerican Depository Receipt Common
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-05-06
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
VALN

Detail

Enriched 2026-08-14 20:47

Market cap
$566,764,013.1
Shares outstanding (class)
94,885,619
Shares outstanding (weighted)
102,119,642
SIC
Employees
674
Location
Description

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data